Explore

Trendline Trendline
Augurex Wins ADLM Immunology Award for Diagnostic Biomarker Research

Augurex Wins ADLM Immunology Award for Diagnostic Biomarker Research

Augurex Wins ADLM Immunology Award for Diagnostic Biomarker Research
Rapid Read Rapid Read
UCLA Study Suggests Creatine Supplements May Enhance Cancer-Fighting Immune Cells

UCLA Study Suggests Creatine Supplements May Enhance Cancer-Fighting Immune Cells

Researchers at the University of California, Los Angeles (UCLA) have discovered that creatine supplements, commonly used for muscle building, may also play a role in cancer treatment. The study, published in iScience, indicates that creatine can enhance the function of dendritic cells, which are crucial for activating the body's killer T cells to fight cancer. The research team found that dendritic cells from tumors produced more of the creatine transporter protein (CrT) than those from healthy tissue, suggesting a potential mechanism for creatine's role in boosting immune response. By experimenting with dendritic cells lacking CrT, researchers observed reduced activity and effectiveness in preparing T cells to combat tumors. This study builds on previous findings that creatine boosts killer T cell activity, suggesting a broader role in energizing the immune infrastructure.
Rapid Read Rapid Read
Study Links Unhealthy Gut to Breast Cancer Metastasis, Suggests New Treatment Avenues

Study Links Unhealthy Gut to Breast Cancer Metastasis, Suggests New Treatment Avenues

A recent study conducted by the University of Virginia Comprehensive Cancer Center has revealed that an unhealthy gut microbiome may contribute to the spread of hormone receptor-positive breast cancer. The research, led by Melanie Rutkowski, Ph.D., indicates that an imbalance in gut microorganisms can lead to a buildup of bile acids, which disrupts metabolism and immune function, creating conditions conducive to cancer metastasis. The study highlights that hormone receptor-positive breast cancer is the most common form of metastatic breast cancer, affecting approximately 225,000 American women annually. The findings suggest that modifying bile acid composition or using bile acid sequestrants, which are already FDA-approved for metabolic diseases, could potentially reduce cancer spread.
Rapid Read Rapid Read
UCLA Study Finds Creatine Supplements May Enhance Cancer Treatment by Boosting Immune Response

UCLA Study Finds Creatine Supplements May Enhance Cancer Treatment by Boosting Immune Response

Researchers at the University of California, Los Angeles (UCLA) have discovered that creatine supplements, commonly used for muscle building, may also play a significant role in cancer treatment. The study, published in iScience, reveals that creatine can enhance the function of dendritic cells, which are crucial for activating the body's killer T cells to fight cancer. The research team found that dendritic cells from tumors produce more of the creatine transporter protein, which facilitates creatine's entry into cells, compared to those from healthy tissue. By experimenting with dendritic cells lacking this transporter, the researchers observed reduced activity and effectiveness in preparing T cells for an anti-cancer response. This suggests that creatine not only supports T cells but also energizes the entire immune infrastructure involved in combating cancer.
Rapid Read Rapid Read
UCLA Study Suggests Creatine Supplements May Enhance Cancer Treatment

UCLA Study Suggests Creatine Supplements May Enhance Cancer Treatment

Researchers at the University of California, Los Angeles (UCLA) have discovered that creatine supplements could play a role in cancer treatment by boosting the activity of dendritic cells, which are crucial in the immune response against tumors. The study, published in iScience, found that creatine injections in mice slowed tumor growth and increased the activity of dendritic cells. These cells, which help detect tumor cells and activate killer T cells, showed enhanced function when supplemented with creatine. The research also explored the effects of creatine on human dendritic cells in a laboratory setting, suggesting potential benefits for human cancer therapy.
Rapid Read Rapid Read
Israeli-Led Team Secures Grant for AI MRI in Ovarian Cancer Detection

Israeli-Led Team Secures Grant for AI MRI in Ovarian Cancer Detection

A research team led by the Technion in Israel has received a grant from the Gray Foundation to develop an AI-powered MRI method for early detection of ovarian cancer. The project focuses on women with BRCA gene mutations, who are at higher risk for the disease. The initiative aims to improve screening processes and reduce the need for preventive surgeries, which can have significant consequences. The team will utilize advanced MRI imaging and AI tools to identify early markers of ovarian cancer, potentially transforming clinical screening practices.
Trendline Trendline
Financial Planner's Advice Leads to Prostate Cancer Diagnosis for Winnipeg Man

Financial Planner's Advice Leads to Prostate Cancer Diagnosis for Winnipeg Man

Financial Planner's Advice Leads to Prostate Cancer Diagnosis for Winnipeg Man
Rapid Read Rapid Read
New Imaging Method Enhances Cancer Tracking from Whole Body to Cellular Level

New Imaging Method Enhances Cancer Tracking from Whole Body to Cellular Level

Researchers have developed a new imaging method that allows for the tracking of cancer progression from the whole body down to individual cells. This approach combines multiple imaging techniques, such as PET scans, bioluminescence, and fluorescence, to detect tumors across the body and examine them in detail. The method, demonstrated in liver and lung cancer models, provides a clearer understanding of tumor behavior at both macro and micro levels. This advancement could lead to more precise cancer treatments by allowing researchers to study tumors individually rather than treating them as biologically identical. The study, led by Professor David Lewis from the Cancer Research UK Scotland Institute and University of Glasgow, is published in Nature Biotechnology.
Rapid Read Rapid Read
New Blood Test May Predict Alzheimer's Symptom Onset, Offering Hope for Early Intervention

New Blood Test May Predict Alzheimer's Symptom Onset, Offering Hope for Early Intervention

A new blood test under development, funded by the National Institutes of Health (NIH), shows promise in predicting when Alzheimer's symptoms are likely to appear. This test focuses on circular RNAs (circRNAs), small loops of genetic material that reflect recent changes in the brain, unlike traditional tests that detect amyloid plaques. Researchers at Washington University School of Medicine identified 34 circRNAs associated with Alzheimer's, which could predict symptom onset two to four years in advance. This advancement could help doctors determine the optimal timing for initiating treatments targeting amyloid plaques, potentially improving patient outcomes and clinical trial designs.
Trendline Trendline
Incyte Presents Promising Data on Cancer Treatments at ESMO Congress 2026

Incyte Presents Promising Data on Cancer Treatments at ESMO Congress 2026

Incyte Presents Promising Data on Cancer Treatments at ESMO Congress 2026
Rapid Read Rapid Read
Johns Hopkins Surgeon Highlights AI Breakthrough in Early Pancreatic Cancer Detection

Johns Hopkins Surgeon Highlights AI Breakthrough in Early Pancreatic Cancer Detection

Dr. Peter A. Najjar, a surgeon and clinical innovation vice president at Johns Hopkins Health System, discussed the transformative role of artificial intelligence (AI) in cancer care on FOX Business. AI is being used to detect pancreatic cancer earlier than traditional methods, potentially improving survival rates. Pancreatic cancer is notoriously deadly due to late diagnosis, with a five-year survival rate of just 13%. However, early detection can increase this rate to 44%. AI models are helping researchers identify patterns in cancer detection that would take physicians decades to recognize. This technology is also accelerating drug discovery by allowing scientists to test treatments using computer models before laboratory testing.
Trendline Trendline
Insmed's PAH Drug Shows Long-Term Efficacy, Projected to Reach $6 Billion in Sales

Insmed's PAH Drug Shows Long-Term Efficacy, Projected to Reach $6 Billion in Sales

Insmed's PAH Drug Shows Long-Term Efficacy, Projected to Reach $6 Billion in Sales